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The heart is formed from cardiogenic progenitors expressing the transcription factors Nkx2-5 and Isl1 (refs 1 and 2). These multipotent progenitors give rise to cardiomyocyte, smooth muscle and endothelial cells, the major lineages of the mature heart 3, 4 . Here we identify a novel cardiogenic precursor marked by expression of the transcription factor Wt1 and located within the epicardium-an epithelial sheet overlying the heart. During normal murine heart development, a subset of these Wt1 1 precursors differentiated into fully functional cardiomyocytes. Wt1 1 proepicardial cells arose from progenitors that express Nkx2-5 and Isl1, suggesting that they share a developmental origin with multipotent Nkx2-5 1 and Isl1 1 progenitors. These results identify Wt1 1 epicardial cells as previously unrecognized cardiomyocyte progenitors, and lay the foundation for future efforts to harness the cardiogenic potential of these progenitors for cardiac regeneration and repair.
Epicardial cells migrate from the proepicardium, an outgrowth of the septum transversum, and spread over the surface of the heart 5, 6 . A subset of epicardial cells transition to a mesenchymal phenotype, migrate into the subjacent myocardium and differentiate into smooth muscle and endothelial cells ( Supplementary Fig. 1 ) [7] [8] [9] [10] [11] [12] [13] . Wt1 was expressed in proepicardium and epicardium, but not in myocardium (Fig. 1a-c) . To trace the fate of Wt1-expressing proepicardial and epicardial cells, a GFPCre complementary DNA 14 was knocked into the endogenous Wt1 start codon ( Supplementary Fig. 2 ). GFP and Cre expression in Wt1
GFPCre/1 embryos co-localized with Wt1, indicating that the knockin strategy placed GFPCre under the control of endogenous Wt1 regulatory elements (Fig. 1d-f ). In the heart, GFPCre expression was confined to proepicardium and epicardium from embryonic day (E) 9.5 to E15.5, and was not found in the myocardium (Fig. 1d-g ).
We used Wt1 GFPCre and the Cre-activated reporters Rosa26 fsLz (ref. 15) and Z/Red (ref. 16 ) to analyse the fate of Wt1-expressing cells in the heart. On Cre-mediated recombination, these reporters heritably express b-galactosidase (b-gal) or red fluorescent protein (RFP), respectively. The use of two different reporters minimized potential artefacts related to unanticipated behaviour of Cre-activated reporters, or to false-positive immunostaining. Whereas Wt1 and GFPCre expression were confined to the epicardium, descendants of Wt1-expressing progenitors (hereafter called Wt1-derived cells), marked by b-gal, were found in a mosaic pattern throughout the myocardium (Fig. 2a) . Consistent with previous reports showing that epicardially-derived mesenchyme predominately differentiates into smooth muscle cells in mammals, most Wt1-derived cells adopted a smooth muscle cell fate, and only a minority differentiated into endothelial cells ( Supplementary Fig. 3 ) 8, 9 . Notably, we found that some Wt1-derived cells differentiated into cardiomyocytes during normal heart development, as demonstrated was expressed in proepicardium (PE) and in scattered pericardial cells over the surface of the heart (arrowheads in magnified image of inset 2). b, c, At E15.5, Wt1 expression was confined to the epicardium, as determined by in situ hybridization (ISH, b) and immunohistochemistry (c). d-f, Coexpression of Wt1 and GFPCre in Wt1 GFPCre/1 E9.5 embryos. Wt1 and GFPCre were co-expressed in proepicardium and urogenital ridge (UR). g, Wt1-driven GFPCre was confined to the epicardium (arrowheads) and not detected within the myocardium at E9.5-E15.5 (representative images for E10.5, E12.5 and E14.5 are shown). Arrows indicate autofluorescent red blood cells. All images except b show immunohistochemical staining. A, atrium; V, ventricle; LV and RV, right and left ventricle, respectively; Lu, lung; OFT, outflow tract; scale bars, 50 mm.
by co-expression of lineage tracers and cardiomyocyte markers cardiac troponin T2 (Tnnt2) and sarcomeric-actinin (Actn1) (Fig. 2b-d) . The Wt1-derived cardiomyocytes also expressed cardiac transcription factors Gata4 and Nkx2-5 ( Supplementary Fig. 4 ). Wt1-derived cardiomyocytes were located in the myocardium of all four cardiac chambers and in the interventricular septum, constituting 7%-10% of cardiomyocytes in ventricles and 18% in atria ( Supplementary Fig. 5 ). We further confirmed co-expression of cardiomyocyte and lineage tracers in isolated cells by immunostaining of dissociated fetal heart cultures ( Fig. 2e-f) . Four per cent of cardiomyocytes in dissociated fetal heart cultures were Wt1-derived ( Supplementary Fig. 5 ), comparable to the frequency observed in tissue sections.
To determine if Wt1-derived cardiomyocytes had functional properties of cardiomyocytes, we analysed dissociated cells from Wt1
GFPCre/1 ;Z/Red fetal hearts. A subset of red fluorescent cells exhibited spontaneous contractile activity ( Fig. 2g and Supplementary Movie 1). In addition, these contracting RFP 1 cells exhibited calcium oscillations, with kinetics, amplitude and frequency characteristic of cardiomyocytes (Fig. 2h-j and Supplementary Movie 2). Also characteristic of cardiomyocytes were calcium 'sparks' preceding calcium waves ( Fig. 2h-1 ) and caffeine augmentation of calcium transient amplitude (Fig. 2j) , consistent with calcium release from cardiomyocyte ryanodine receptors. Calcium transients of RFP 1 cells were indistinguishable from, and synchronous with, adjacent RFP 2 cells (Fig. 2i) , suggesting electrical coupling between Wt1-derived and non-Wt1-derived cardiomyocytes. Consistent with this finding, the gap junction protein connexin 43 (Cx43) localized to the membrane between Wt1-derived and neighbouring cardiomyocytes (Supplementary Fig. 6a) . A similar pattern of Cx43 expression was observed in Wt1-derived cardiomyocytes in tissue sections of E15.5 hearts (Supplementary Fig. 6b ), suggesting that Wt1-derived cardiomyocytes are also electrically coupled to other cardiomyocytes in vivo. Collectively, these data indicate that during heart development a subset of Wt1-expressing cells differentiate into cardiomyocytes.
To characterize the Wt1-expressing cardiomyocyte precursors further, we used several independent methods to control the temporal and spatial window during which these precursors were labelled. To regulate Cre-labelling temporally, we knocked a cDNA encoding a Cre-modified oestrogen receptor ligand-binding domain (CreERT2) into the Wt1 locus ( Supplementary Fig. 7 ). CreERT2 fusion protein recombinase activity requires tamoxifen 17 . Maternal injection of tamoxifen at E10.5 and E11.5 induced Cre activity and resulted in b-gal expression within Wt1
CreERT2 ;Rosa26
whereas Wt1
CreERT2 did not activate Rosa26 fsLz in the absence of tamoxifen ( activation by tamoxifen concentrations compatible with maintenance of pregnancy. Co-staining for differentiation markers showed that b-gal 1 cells differentiated into cardiomyocyte, endothelial and smooth muscle cell lineages (Fig. 3c-e) . The distribution of labelled cells between these lineages was comparable between pulse and constitutive labelling approaches. We verified co-expression of cardiomyocyte markers and pulse-labelled lineage tracers at the single cell level by staining cardiomyocytes dissociated from E16.5 Wt1
CreERT2/1 ;Z/Red hearts, pulsed with tamoxifen at E10.5 and E11.5 ( Fig. 3f-h ). We consistently observed these pulse-labelled cardiomyocytes, although the frequency (0.02 6 0.01%) was notably less than with constitutive labelling with Wt1
GFPCre . Within the window of the tamoxifen pulse, cardiac Wt1 expression was confined to the epicardium (Fig. 1) . On the basis of these data, we conclude that a subset of epicardial cells expressing Wt1 differentiate into cardiomyocytes.
To delimit the location of Wt1-expressing cells that differentiate into cardiomyocytes further, we microdissected E11.5 Wt1
GFPCre/1 ;Z/Red fetal hearts. Serial enzymatic digestion of intact hearts yielded epicardial cells preferentially in the early fractions due to their location on the exterior of the heart. Early (epicardial) and late (negative control) digestion fractions were sorted for GFP fluorescence, yielding a population enriched for active GFP expression (Fig. 3i) . These GFP 1 cells were plated onto either mitotically inactivated cardiac feeders (Fig. 3j) or untreated tissue culture dishes (Fig. 3k) . In both conditions a subset of the sorted Wt1
GFPCre/1 ;Z/ Red cells differentiated into cardiomyocytes, identified by coexpression of the RFP lineage tracer and cardiomyocyte markers (Fig. 3j-k) . These data provide further evidence that a subset of heart cells actively expressing Wt1, confined within epicardium at E10-11.5 (Fig. 1) , differentiate into cardiomyocytes.
We obtained further independent evidence that epicardial cells differentiate into cardiomyocytes by selective dye labelling of epicardium in E11.5 explanted hearts (Fig. 3l) . Explanted hearts were briefly incubated in culture media containing the dye CMFDA and then placed in culture media without dye. This resulted in selective labelling of epicardium, as confirmed in sections of hearts fixed immediately after CMFDA incubation (Fig. 3l, 0 h ). After two days of explant culture, labelled epicardial cells were found within the myocardium, and a subset expressed the cardiomyocyte marker Nkx2-5 (Fig. 3l, 48 h) . The presence of dye and the cardiomyocyte markers Nkx2-5, Tnni3 and Actn1 within the same cell was further demonstrated in single cells isolated by dissociating heart explants two days after labelling (Fig. 3m) . Collectively, these data indicate that precursors actively expressing Wt1 within E10.5-E11.5 epicardium differentiate into cardiomyocytes.
Reported
IRESCre knock-in allele 18 , we found that Nkx2-5-driven-Cre activated Rosa26 fsLz in a subset of proepicardium cells (Fig. 4a, b) , suggesting that the descent of Wt1 1 proepicardium cells from Nkx2-5-expressing cells occurs.
We independently corroborated this result using a different Nkx2-5 knock-in allele, Nkx2- 
Wt1
CreERT2 did not recombine the fate mapping reporter Rosa26 fsLz in the absence of tamoxifen (Tam.) injection (b). Tamoxifen treatment at E10.5 and E11.5 induced Wt1
CreERT2 labelling of cardiomyocytes, as determined in both tissue sections (c) and in dissociated heart culture (g-h). Also labelled were smooth muscle cells, marked by expression of the platelet derived growth factor receptor b (PDGFR), adjacent to endothelial tubes, marked by expression of platelet/endothelial cell adhesion molecule 1 (Pecam) (d, e) . i-k, E11.5 Wt1
GFPCre/1 heart cells actively expressing Wt1, as determined by GFP fluorescence, differentiated into cardiomyocytes. Wt1 1 epicardial cells were enriched in early digestion fractions compared to late digestion fractions (i, FACS analysis). GFP 1 cells from early fractions were plated either with mitotically inactivated feeders (j) or without feeders (k). l, m, CMFDA dye, selectively incorporated into E11.5 epicardium, was found in cardiomyocytes at 48 h. Brief incubation of E11.5 heart explants with the dye CMFDA resulted in selective labelling of epicardium (0 h culture). After 48 h in explant culture, dye-labelled cells were present in the myocardial wall (l). A subset of dye-labelled cells co-expressed the cardiomyocyte markers Nkx2-5, cardiac troponin I (Tnni3) and Actn1 (m). Arrows indicate co-expression; scale bars represent 10 mm.
endothelial cell compartments of the myocardium, as well as in proepicardium ( Supplementary Fig. 9 ) [20] [21] [22] . Therefore, within this domain, endogenous Gata4 regulatory elements can be used to drive expression of a Cre-dependent reporter gene, alkaline phosphatase; we generated such a reporter, Gata4 flap ( Supplementary Fig. 10 ). In the absence of Cre, Gata4 flap did not express alkaline phosphatase (Supplementary Fig. 10 ). In the presence of well-characterized Cre transgenes, Gata4 flap expressed alkaline phosphatase in patterns consistent with the expected sites of Cre activity (Cre driven by the cardiac troponin (cTnTCre) and myosin heavy chain a (Myh6Cre) promoters in myocardium, and by the endothelial-specific receptor tyrosine kinase promoter (Tie2Cre) in endothelium; Supplementary  Fig. 10 flap demonstrated a robust contribution of Nkx2-5-expressing progenitors to proepicardium (Fig. 4c, asterisk) . The Nkx2-5
Cre -labelled proepicardium cells expressed Wt1 (Fig. 4d) 
Gata4
flap also showed a robust contribution of Isl1-expressing precursors to the Wt1 1 cells in proepicardium ( Supplementary Fig. 11b ). Supporting this finding, Wt1 and Isl1 were expressed in adjacent regions at E8.0 and a subset of cells was positive for both markers ( Supplementary Fig. 12a, b) .
Although Wt1 1 cells in proepicardium were labelled by Nkx2-5-driven Cre, they did not actively co-express Nkx2-5 at E9.5 (Fig. 4e) . In E8.0 embryos, Nkx2-5 and Wt1 were expressed in adjacent cells, but were not co-expressed (Supplementary Fig. 12c) 
GFP embryonic stem cells 4 and fluorescence-activated cell sorting (FACS), we isolated Nkx2-5-expressing cells at several time points during embryoid body differentiation. Wt1 was transiently upregulated in Nkx2-5 1 cells during embryonic stem cell differentiation (Fig. 4f) . This result was specific, as we did not detect significant Wt1 expression in parallel experiments with Mef2c-AHF-GFP embryonic stem cells 23 (data not shown). In embryos, the activity domain of the Mef2c-AHF enhancer (which was 'on' in anterior heart field, 'off' in proepicardium) did not overlap with the Wt1 expression domain 24 ( Fig. 4e, yellow arrowhead) . Collectively, these data suggest that Nkx2-5 and Wt1 are either sequentially expressed or transiently co-expressed in a subset of proepicardium precursors.
We have shown that Wt1 1 proepicardium and epicardial cells contribute to the cardiomyocyte lineage during normal heart development ( Supplementary Fig. 1 ). Wt1 1 cells located on the heart at E10.5-E11.5 differentiate into functional cardiomyocytes. Although differentiation of proepicardium cells into cardiomyocytes was previously noted in vitro 25 , previous fate-mapping studies of proepicardium cells, using retroviral labels in chick or transgene labels in mice, did not describe proepicardium contribution to the cardiomyocyte lineage in vivo [8] [9] [10] 12, 13 . This may be attributable to differences in methodology, species or domains of transgene activity. Consistent with the capacity of Wt1-expressing cells to differentiate into cardiomyocytes, Wt1 1 proepicardium and epicardial cells are derived from progenitors that express Nkx2-5 and Isl1, suggesting that they share a common developmental origin with previously described multipotent cardiogenic progenitors 1,2 . These experiments have identified a previously unrecognized cardiomyocyte progenitor population in the developing heart that may be of use for cardiac regeneration or repair.
METHODS SUMMARY
Gene targeting and mouse lines are described in Methods. Fetal hearts were dissociated by serial digestion with collagenase and trypsin. For calcium imaging, dissociated fetal heart cultures were loaded with Fluo-4 AM and imaged with an Olympus FV1000 confocal microscope. Cardiac feeders were prepared and mitotically inactivated as described 26 . Nkx2-5 GFP and Mef2c-AHF-GFP embryonic stem cells were differentiated in embryoid body culture and sorted for GFP fluorescence as described previously 4, 23 . Immunohistochemistry was performed according to standard methods, using primary and secondary antibodies listed in Supplementary Table 1 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
METHODS

Gene targeting. Wt1
GFPCre , Wt1
CreERT2 and Gata4 flap targeting vectors were constructed using Red/ET recombineering 27 . The Wt1 targeting strategy removed the first coding exon. The Gata4 flap targeting strategy replaced the first coding exon with a loxP-Gata4 cDNA-transcription stop-loxP-alkaline phosphatase cDNA-Frt-pgkneo-Frt cassette. Gene targeting was confirmed by Southern blotting and PCR. Chimaeric mice were mated to ActB::Flpe mice 28 to remove the neomycin resistance cassette. Mice. Nkx2-5
Cre , Nkx2-5
Cre , Myh6aCre, cTntCre, Tie2Cre, Z/Red and Rosa26 fsLz mice were described previously 15, 16, 18, 19, [29] [30] [31] . Wt1 CreERT2 was induced with tamoxifen. Tamoxifen (Sigma) was dissolved in ethanol at 100 mg ml 21 and then emulsified in sesame oil to a final concentration of 12.5 mg ml 21 . Two milligrams were injected intraperitoneally at E10.5 and E11.5. Mice were used in accordance with protocols approved by the Institutional Animal Care and Use Committee. Tissue culture. Heart dissociation was performed by serial digestion with collagenase and trypsin, as described for neonatal hearts 32 . Cardiomyocytes were cultured on fibronectin-treated tissue culture dishes or glass coverslips using media M199 containing 10% fetal bovine serum, penicillin and streptomycin. For explant culture, hearts were excised and incubated in 1 mM CMFDA (Invitrogen) for 15 min at 37 uC. Hearts were washed twice and then incubated in DMEM containing 10% FBS, penicillin and streptomycin. RNA expression. RNA expression was measured by quantitative real-time PCR using Sybr Green. Primers for Wt1 were: forward, GCCTTCACCT TGCACTTCTC; reverse, GACCGTGCTGTATCCTTGGT. Gene expression was normalized to GAPDH, detected using proprietary primers and probes (Applied Biosystems). Wt1 in situ hybridization with digoxigenin-labelled probes was performed as described previously 33 . Immunohistochemistry. All procedures were performed according to standard protocols from Vector Laboratories and Jackson Immunoresearch or as described previously 34 . The sources and dilutions of primary and secondary antibodies are listed in Supplementary Table 1. The Cx43 antibody was a gift from D. Gutstein 35 . Weak signals were detected using a secondary antibody conjugated to polymerized peroxidase (Invitrogen) and then incubation with substrate DAB (Vector), tyramide-Cy3 (Perkin-Elmer) or tyramide-Alexa488 (Invitrogen).
b-galactosidase and alkaline phosphatase activity were detected as described previously 36 . Alkaline phosphatase was detected with either BCIP/NBT or Permanent Red (Dako). Permanent Red fluorescence was detected in the Cy5 channel of an FV1000 confocal microscope. Immunohistochemical studies of Wt1
CreERT2 labelling were performed blinded to tamoxifen treatment group.
